Expertise in
61
conditions

Dr. Courtney M. Bellomo

Hematology
Office
3 Crossing Blvd, 
Clifton Park, NY 
Offers Telehealth
Expertise in
61
conditions
Office
3 Crossing Blvd, 
Clifton Park, NY 

Overview

Courtney Bellomo is a Hematologist practicing medicine in Clifton Park, New York.

Dr. Bellomo is highly rated in 61 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 3 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in NY

Hospital Affiliations

Columbia Memorial Hospital
Samaritan Hospital Of Troy, New York
Albany Medical Center Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Office
3 Crossing Blvd, Clifton Park, NY 12065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Biological
Study Drug: lisocabtagene maraleucel
Study Phase: Phase 2
A Phase 2 Study of Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL (017006)
A Phase 2 Study of Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL (017006)
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Biological
Study Drug: Lisocabtagene maraleucel
Study Phase: Phase 2
View 2 Less Clinical Trials

3 Total Publications

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
Journal: Blood advances
Published: March 25, 2024
Similar Doctors
Expertise in
46
conditions
Dr. Makenzi Evangelist
Hematology | Oncology
Expertise in
46
conditions
Dr. Makenzi Evangelist
Hematology | Oncology
Referral may be required

New York Oncology Hematology Clifton Park Cancer Center

3 Crossing Blvd Ste 1, 
Clifton Park, NY 
 (0.7 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Makenzi Evangelist is a Hematologist and an Oncologist practicing medicine in Clifton Park, New York. Dr. Evangelist is highly rated in 46 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Non-Small Cell Lung Cancer (NSCLC).

Expertise in
56
conditions
Dr. Howard Schlossberg
Hematology | Oncology
Expertise in
56
conditions
Dr. Howard Schlossberg
Hematology | Oncology
Referral may be required

Office

3 Crossing Blvd, 
Clifton Park, NY 
 (0.1 miles away)
518-831-4434
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Howard Schlossberg is a Hematologist and an Oncologist practicing medicine in Clifton Park, New York. Dr. Schlossberg is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Thrombocytopenia, Colorectal Cancer, and Paget Disease of the Breast.

Expertise in
44
conditions
Dr. Adriana Lisinschi
Hematology | Oncology | Internal Medicine
Expertise in
44
conditions
Dr. Adriana Lisinschi
Hematology | Oncology | Internal Medicine
Referral may be required

New York Oncology Hematology Clifton Park Cancer Center

3 Crossing Blvd Ste 1, 
Clifton Park, NY 
 (0.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Adriana Lisinschi is an Oncologist and an Internal Medicine provider practicing medicine in Clifton Park, New York. Dr. Lisinschi is highly rated in 44 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Melanoma, and Pleuropulmonary Blastoma. Dr. Lisinschi is board certified in American Board Of Internal Medicine Subspecialty, Hematology and American Board Of Internal Medicine Subspecialty, Medical Oncology. Dr. Lisinschi is currently accepting new patients.

Frequently Asked Questions about Dr. Courtney M. Bellomo

How do I make an appointment with Dr. Courtney M. Bellomo?

You can book an appointment with Dr. Courtney M. Bellomo by calling their office at 518-831-4434. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Courtney M. Bellomo a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Courtney M. Bellomo is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Courtney M. Bellomo specialize in?

While Dr. Courtney M. Bellomo is a Hematology, they have specific expertise in Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Courtney M. Bellomo participate in research or clinical trials?

Yes. Dr. Courtney M. Bellomo has published 3 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Courtney M. Bellomo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Courtney M. Bellomo accept my insurance?

Dr. Courtney M. Bellomo accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 518-831-4434 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bellomo's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 51 Advanced Conditions
    View All 74 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile